NEW YORK (GenomeWeb News) – Kinaxo Biotechnologies today said that it has received a grant from the Bavarian Research Foundation to expand applications of its quantitative phosphoproteomics platform to drug efficacy studies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.